Stay updated on Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has updated its revision number from v3.5.3 to v3.5.4, indicating a minor site update. The update does not alter the displayed study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T05:22:27.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.2 to v3.5.3, representing a new build of the site. This update does not alter the study details or any information presented to users.
    Difference
    0.1%
    Check dated 2026-04-30T18:35:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown, replacing Revision: v3.5.0. This indicates a site update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:12.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:44:50.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page metadata.
    Difference
    0.1%
    Check dated 2026-03-11T14:48:04.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    The new screenshot shows minor layout and styling updates (e.g., spacing and header tweaks). There are no changes to core study data such as eligibility criteria, outcomes, enrollment, or results.
    Difference
    0.1%
    Check dated 2026-02-18T04:14:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.